Who are the key players in US Extracorporeal Membrane Oxygenation Machine industry?

The top five players in the US Extracorporeal Membrane Oxygenation (ECMO) machine market are Getinge AB, Medtronic, Abbott Laboratories, Terumo Corporation, and Fresenius Medical Care. These companies are recognized for technological innovation, comprehensive product portfolios, and strong distribution networks dedicated to supporting advanced cardiopulmonary critical care solutions.

What is the US Extracorporeal Membrane Oxygenation Machine growth?

The US ECMO machine market has experienced significant growth, particularly post-COVID-19, with demand fueled by increased incidence of severe respiratory failure. Companies like Getinge AB reported notable revenue increases in 2023 as hospitals expand capacities for advanced life-support equipment.

Which segment accounted for the largest US Extracorporeal Membrane Oxygenation Machine share?

The largest US ECMO machine market share is held by the respiratory application segment. The demand is attributed to rising cases of acute respiratory distress syndrome (ARDS) and other severe lung conditions, where ECMO serves as an essential lifesaving intervention in critical care settings.

What are the factors driving the US Extracorporeal Membrane Oxygenation Machine?

Key drivers include technological advancements, increased prevalence of cardiovascular and respiratory diseases, and expanded awareness of ECMO's efficacy. For example, Medtronic has accelerated new technology launches to meet the growing need for advanced extracorporeal support during critical illnesses.

Which type accounted for the largest US Extracorporeal Membrane Oxygenation Machine share?

The veno-arterial (VA) ECMO machine type dominates the US market, primarily used for patients requiring both cardiac and respiratory support. Its broad application in severe cardiac failure cases makes VA ECMO the preferred choice among healthcare providers for life-saving interventions.

Home Medical Devices

US Extracorporeal Membrane Oxygenation Machine Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: US Extracorporeal Membrane Oxygenation Machine
Brand: Bussiness Insights

US Extracorporeal Membrane Oxygenation Machine Market: by Type (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), Distribution Channels (Direct Tender, Retail Sales, E-commerce), Technology (Pumps, Oxygenators, Controllers, Accessories), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20155 | Author: Ankita R

RD TOC Segmentation Research Methodology Request For Free Sample

US Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook to 2035

The US ECMO machine market is anticipated to witness significant expansion due to technological advancements and rising cases of respiratory and cardiac conditions. ECMO machines provide critical life support for patients with severe heart and lung dysfunctions by oxygenating blood outside the body, serving as a bridge to recovery or transplantation. Its applications range from acute respiratory distress syndrome to cardiac arrest and congenital heart diseases. In recent years, innovations such as portable ECMO units and integrated monitoring systems have improved outcomes and workflow efficiency. Healthcare providers are increasingly embracing ECMO therapies amidst a growing aging population and elevated incidents of chronic respiratory illnesses. However, high device costs and stringent regulations continue to challenge market growth. The US market is expected to experience a robust CAGR through 2035, driven by strong investments, favorable reimbursement policies, and a growing focus on advanced critical care infrastructure.

Latest Market Dynamics

Key Drivers

Technological advancements in ECMO systems: Companies like LivaNova PLC are developing portable and integrated ECMO solutions for greater mobility and faster deployment in emergency scenarios.
Rising adoption of ECMO in pediatric and neonatal care: Organizations such as Boston Scientific Corporation are focusing on ECMO machines designed specifically for younger patients, reflecting a trend towards specialized solutions in critical care.

Expansion into smaller hospitals and rural care settings: Companies like Xenios AG are targeting mid-tier and rural hospitals, creating opportunities to broaden ECMO access beyond urban tertiary care centers.
Integration of digital health and data analytics: Firms including Terumo Corporation are innovating real-time monitoring and telehealth integration for ECMO systems, enhancing outcome prediction and personalized care.

High cost of ECMO equipment and maintenance: The significant investment required for ECMO acquisition and operation presents challenges for budget-constrained institutions. Nipro Corporation has worked to lower cost barriers through financing and leasing models.
Shortage of trained ECMO specialists: Ensuring skilled staff for ECMO operation remains a bottleneck, despite training programs established by Abiomed across major US hospitals.

Stringent regulatory approvals: The ECMO market encounters delays due to rigorous FDA requirements for safety and efficacy, affecting companies like Eurosets Srl in the introduction of new devices.
Potential complications and risks associated with ECMO therapy: Adverse events such as bleeding and thrombosis, as seen with Hemovent GmbH’s devices, prompt cautious adoption and reinforce the need for continuous product improvement.

The US ECMO machine market in 2025 is primarily dominated by Veno-Arterial (VA) ECMO, which accounts for the largest market share due to its broad application in cardiac and cardiopulmonary cases. Veno-Venous (VV) ECMO also constitutes a significant segment driven by the rise in respiratory failure treatments. Peripheral ECMO solutions are seeing increasing adoption due to their minimally invasive approach and faster deployment. Hybrid and central ECMO systems capture smaller shares, catering to highly specific complex clinical requirements. The robust presence of VA and VV ECMO emphasizes a clinical focus on immediate life-threatening conditions, supported by technological advancements and expansion efforts from leading manufacturers.

Within the US ECMO machine market by 2025, the dominant application segment remains respiratory indications, which capture the highest share due to surging cases of ARDS attributed to infections and chronic illnesses. Cardiac applications follow closely, propelled by an increasing incidence of advanced heart failure, post-cardiotomy support, and ECPR deployment in critical care. The ECPR segment, while smaller, is gaining traction as healthcare providers recognize its life-saving benefits during cardiac arrest scenarios where conventional resuscitation fails. The distribution of shares reflects the ongoing prioritization of life-threatening respiratory and cardiac scenarios in US healthcare delivery and greater availability of specialized ECMO teams in major hospitals.

The US ECMO machine market revenue trajectory is on a consistent rise, starting at $400 million in 2020, increasing to $600 million in 2025, and forecasted to reach $1,250 million by 2035. Growth is fueled by expanding awareness, higher adoption in diverse care settings, and continual technological innovation by market leaders. The increased demand for critical care devices and successful integration of ECMO into advanced cardiopulmonary support protocols play pivotal roles. This revenue progression underscores not only expanding utilization but also reflects the impact of favorable reimbursement, ongoing clinical studies, and broadening indications for ECMO therapy in the US.

Year-over-year growth rates in the US ECMO market show strong performance, with a surge to 9.2% in 2021, followed by a steady rate of 8.1% in 2025 as the market matures. Expansion slows slightly to 6.3% by 2030 and 5.0% in 2035, characteristic of a market entering its consolidation phase. This pattern illustrates robust early adoption, followed by stabilization as technological diffusion and market penetration advance among healthcare providers.

Regional market share for ECMO machines in the US demonstrates a strong concentration in the Northeast, accounting for the largest percentage driven by a high density of academic hospitals and specialized cardiac centers. The South reflects growth in both adoption and hospital capacity, while the Midwest continues to expand with several large teaching facilities adding ECMO programs. The West rounds out the market with increasing investment in technology and rising demand due to population growth. Regional disparities underline differences in healthcare infrastructure, funding, and specialist availability.

In 2025, the US ECMO market is notably led by Medtronic, reflecting its extensive product portfolio and deep market penetration. Getinge Group follows as a major player, leveraging broad clinical adoption and innovations in integrated ECMO platforms. LivaNova PLC secures a substantial position through investments in portable ECMO technologies and expanding service models. The remaining share is distributed among other global and niche manufacturers, indicating an increasingly competitive landscape with continued growth opportunities for new entrants and established brands alike.

Hospital systems remain the dominant buyers in the US ECMO machine market by 2025, comprising over half the market, as tertiary hospitals and academic medical centers account for most installations. Specialty clinics have increased their purchases, driven by the adoption of ECMO for both acute and chronic indications. The share by group purchasing organizations is growing steadily, reflecting the trend toward cost optimization and bulk procurement. The evolving buyer landscape highlights the push towards wider, more efficient ECMO access across hospital networks and critical care platforms.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	600
Regions	Northeast, South, Midwest, West
Segments	By Type, By Application, By Technology, By Distribution Channels, By Organization Size
Players	Medtronic, Getinge Group, LivaNova PLC, Terumo Corporation, Nipro Corporation, Abiomed, Fresenius Medical Care AG & Co. KGaA, Eurosets Srl, Alung Technologies Inc., Xenios AG, Microport Scientific Corporation, Hemovent GmbH, OriGen Biomedical, Biomedica GmbH, Boston Scientific Corporation

In June 2024, Medtronic announced the US launch of a next-generation portable ECMO platform with advanced monitoring features to support emergency and operating room needs.
Getinge Group expanded its US production capacity in July 2024 to meet increasing demand for ECMO machines in pediatric and adult ICUs.
In August 2024, LivaNova PLC introduced a cloud-based data analytics platform for real-time ECMO patient monitoring across multiple US centers.
In September 2024, Terumo Corporation received expanded FDA clearance for its integrated ECMO with telemedicine connectivity for remote expert support.
Abiomed initiated a partnership in October 2024 with leading US health systems to upskill clinicians in novel ECMO deployment protocols.

About the Author

Ankita R

Lead Industry Analyst

Ankita R is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Medical Devices. Ankita R brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Ankita R has helped organizations translate data into actionable growth strategies.

Medical DevicesMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

US Extracorporeal Membrane Oxygenation Machine Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

US Extracorporeal Membrane Oxygenation (ECMO) Machine Market Outlook to 2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

US ECMO Machine Market Share by Type, 2025

US ECMO Machine Market Share by Applications, 2025

US ECMO Machine Market Revenue (USD Million), 2020-2035

US ECMO Machine Market Year-Over-Year Growth (%), 2020-2035

US ECMO Machine Market by Region, 2025

US ECMO Machine Market Share by Key Players, 2025

US ECMO Machine Market Share by Buyer Type, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports